Korean Journal of Head & Neck Oncology (대한두경부종양학회지)

The Korean Society for Head and Neck Oncology (대한두경부종양학회)
권호 표지
DOI QR코드

DOI QR Code

Head and Neck Oncologic Care During the COVID-19 Pandemic

COVID-19와 두경부암

  • Chang, Jae Won (Department of Otolaryngology-Head and Neck Surgery, Research Institute for Medical Science, Chungnam National University College of Medicine)
  • 장재원 (충남대학교 이비인후과학교실)
  • Received : 2020.05.03
  • Accepted : 2020.05.10
  • Published : 2020.05.31
Download PDF
⟨ Previous Next ⟩

Abstract

It is well established that cancer patients are more susceptible to infection because of the immunosuppressive status caused by both disease itself and anticancer treatment, including surgery and chemoradiation. Head and neck cancer (HNC) patients are generally at high-risk for coronavirus disease 2019 (COVID-19) infection and serious adverse outcomes. Although there is an urgent need for guidance in the delivery of safe, quality oncologic care, no international consented recommendation addressed the management of HNC patients in COVID-19 due to limited data. In this review, we summarized the consideration for head and neck oncologic care in the context of the COVID-19 pandemic, based on the data and the very recent recommendations from the Korean Cancer Association and National Cancer Center. COVID-19 should be taken into consideration in the comprehensive management of HNC patients, and multidisciplinary evaluation of multilevel surgical-risks, discussion of optimized strategy, and shared-decision-making with the patient are needed to maximize both the safety from infectious pandemic and outcome of surgical and oncologic care.

Keywords

References

  1. Day AT, Sher DJ, Lee RC, Truelson JM, Myers LL, Sumer BD, et al. Head and neck oncology during the COVID-19 pandemic: Reconsidering traditional treatment paradigms in light of new surgical and other multilevel risks. Oral Oncology. 2020:104684.
  2. Day AT, Sher DJ, Lee RC, Truelson JM, Myers LL, Sumer BD, et al. Head and neck oncology during the COVID-19 pandemic: Reconsidering traditional treatment paradigms in light of new surgical and other multilevel risks. Oral Oncol. 2020;105:104684. https://doi.org/10.1016/j.oraloncology.2020.104684
  3. Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. The Lancet Oncology. 2020;21:335-337. https://doi.org/10.1016/s1470-2045(20)30096-6
  4. KCA. Recommendations for cancer patient care based on the situation of COVID-19 in Korea; 2020.
  5. van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, et al. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. New England Journal of Medicine. 2020;382:1564-1567. https://doi.org/10.1056/nejmc2004973
  6. Santarpia JL, Rivera DN, Herrera V, Morwitzer MJ, Creager H, Santarpia GW, et al. Transmission potential of SARS-CoV-2 in viral shedding observed at the University of Nebraska Medical Center. medRxiv. 2020.
  7. Mansfield SA, Abdel-Rasoul M, Terando AM, Agnese DM. Timing of Breast Cancer Surgery-How Much Does It Matter? Breast J. 2017;23:444-451. https://doi.org/10.1111/tbj.12758
  8. Al-Shamsi HO, Alhazzani W, Alhuraiji A, Coomes EA, Chemaly RF, Almuhanna M, et al. A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group. Oncologist. 2020.
  9. DeGraaff LH, Platek AJ, Iovoli AJ, Wooten KE, Arshad H, Gupta V, et al. The effect of time between diagnosis and initiation of treatment on outcomes in patients with head and neck squamous cell carcinoma. Oral Oncology. 2019;96:148-152. https://doi.org/10.1016/j.oraloncology.2019.07.021
  10. Graboyes EM, Kompelli AR, Neskey DM, Brennan E, Nguyen S, Sterba KR, et al. Association of Treatment Delays With Survival for Patients With Head and Neck Cancer: A Systematic Review. JAMA Otolaryngol Head Neck Surg. 2019;145:166-177. https://doi.org/10.1001/jamaoto.2018.2716
  11. Ho AS, Kim S, Tighiouart M, Mita A, Scher KS, Epstein JB, et al. Quantitative survival impact of composite treatment delays in head and neck cancer. Cancer. 2018;124:3154-3162. https://doi.org/10.1002/cncr.31533
  12. Jensen AR, Nellemann HM, Overgaard J. Tumor progression in waiting time for radiotherapy in head and neck cancer. Radiother Oncol. 2007;84:5-10. https://doi.org/10.1016/j.radonc.2007.04.001
  13. Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21:335-337. https://doi.org/10.1016/s1470-2045(20)30096-6
  14. Battershill PM. Influenza pandemic planning for cancer patients. Curr Oncol. 2006;13:119-120. https://doi.org/10.3390/curroncol13040012
  15. Harris JP, Chen MM, Orosco RK, Sirjani D, Divi V, Hara W. Association of Survival With Shorter Time to Radiation Therapy After Surgery for US Patients With Head and Neck Cancer. JAMA Otolaryngol Head Neck Surg. 2018;144:349-359. https://doi.org/10.1001/jamaoto.2017.3406
  16. Xiao R, Joshi RR, Husain Q, Cracchiolo JR, Lee N, Tsai J, et al. Timing of surgery and adjuvant radiation therapy for sinonasal malignancies: Effect of surgical approach. Head Neck. 2019;41:3551-3563. https://doi.org/10.1002/hed.25873
  17. Ghanem AI, Schymick M, Bachiri S, Mannari A, Sheqwara J, Burmeister C, et al. The effect of treatment package time in head and neck cancer patients treated with adjuvant radiotherapy and concurrent systemic therapy. World J Otorhinolaryngol Head Neck Surg. 2019;5:160-167. https://doi.org/10.1016/j.wjorl.2018.09.005
  18. Mukherjee RK, Back MF, Lu JJ, Shakespeare TP, Wynne CJ. Hiding in the bunker: Challenges for a radiation oncology department operating in the Severe Acute Respiratory Syndrome outbreak. Australas Radiol. 2003;47:143-145. https://doi.org/10.1046/j.0004-8461.2003.01165.x
  19. ASTRO. COVID-19 recommendations to radiation oncology practices. 2020; Available from: https://www.astro.org/Daily-Practice/COVID-19-Recommendations-and-Information/Summary.
  20. Ueda M, Martins R, Hendrie PC, McDonnell T, Crews JR, Wong TL, et al. Managing Cancer Care During the COVID-19 Pandemic: Agility and Collaboration Toward a Common Goal. J Natl Compr Canc Netw. 2020:1-4.
  21. Numico G, Cristofano A, Mozzicafreddo A, Cursio OE, Franco P, Courthod G, et al. Hospital admission of cancer patients: avoidable practice or necessary care? PLoS One. 2015;10:e0120827. https://doi.org/10.1371/journal.pone.0120827
  22. Kligerman MP, Vukkadala N, Tsang RKY, Sunwoo JB, Holsinger FC, Chan JYK, et al. Managing head and neck cancer patients with tracheostomy or laryngectomy during the COVID-19 pandemic. Head Neck. 2020.
  23. Michetti CP, Burlew CC, Bulger EM, Davis KA, Spain DA. Performing tracheostomy during the Covid-19 pandemic: guidance and recommendations from the Critical Care and Acute Care Surgery Committees of the American Association for the Surgery of Trauma. Trauma Surgery & Acute Care Open. 2020;5:e000482. https://doi.org/10.1136/tsaco-2020-000482
  24. Sommer DD, Engels PT, Usaf C, Khalili S, Corsten M, Tewfik MA, et al. Recommendations from the CSO-HNS taskforce on performance of tracheotomy during the COVID-19 pandemic. J Otolaryngol Head Neck Surg. 2020;49:23. https://doi.org/10.1186/s40463-020-00414-9
  25. Adjei Boakye E, Jenkins W, Sharma A. Disproportionate impact of COVID-19 pandemic on head and neck cancer survivors. Head Neck. 2020.